Pharming Group reports financial results for the first quarter of 2023

FDA approval and commercial launch of Joenja® (leniolisib) in the U.S. Joenja® launch off to strong start with 23 U.S. patients on paid therapy Revenues decreased by 9% to US$42.5 million, compared to the first quarter of 2022, primarily due to temporary reimbursement disruptions for some patients on government insurance programs. This issue, affecting all … Read more

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

UCB’s expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum’s discovery of treatments for solid tumors Ariceum’s expertise in radiopharmaceuticals and labelling technology will aid UCB’s discovery of treatments for immune-related diseases Potential to expand Ariceum’s pipeline with three new programs at discovery stage BERLIN and BRUSSELS, May 11, 2023 … Read more

Antidepressants, really effective against chronic pain?

With one exception, a large review concludes that there is little evidence that antidepressants are effective in this type of prescription. A work published in the Cochrane collaborative database concludes that “Duloxetine is the only antidepressant whose (interest) is indisputable against chronic pain”. The aim was to assess the potential benefits of 25 antidepressants in … Read more

Niklas Prager appointed new CEO of SmartCella

STOCKHOLM, May 11, 2023 /PRNewswire/ — SmartCella Holding AB today announces that Niklas Prager has been appointed as the new CEO. SmartCella is an innovative biotech and medtech company that combines targeted delivery of medical substances to organs and tumors through a unique device, and the development of future stemcell and RNA-based treatments and methods … Read more

BioInnovation Institute appointed by the Danish government to run international deep tech start-up accelerator to unlock the potential in quantum science

COPENHAGEN, Denmark, May 11, 2023 /PRNewswire/ — BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, announces the launch of a new deep tech accelerator start-up program, the Deep Tech Lab – Quantum, to propel emergent and disruptive quantum science and biotechnology solutions toward the marketplace. Deep tech and quantum … Read more

Alameda Health System Publishes the AHS COVID-19 Memory Archive

The archive features short oral history interviews with the health care workers who were on the frontline of COVID-19 in Alameda County, California. OAKLAND, Calif., May 11, 2023 /PRNewswire/ — Alameda Health System (AHS) has published an AHS COVID-19 Memory Archive to commemorate the end of the COVID-19 state of emergency on May 11, 2023. Earlier in … Read more

Nippon Express Italia Obtains IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport

TOKYO, May 11, 2023 /PRNewswire/ — Nippon Express Italia S.p.A. (hereinafter “NX Italia”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired IATA CEIV Pharma certification*, a quality certificate for pharmaceutical transport established by the International Air Transport Association (IATA), for its warehouse facility in Lainate, near Milan Malpensa Airport, effective April 3 of this year. Logo: https://kyodonewsprwire.jp/img/202305095498-O1-I17xe4r6 Photos … Read more

Zooming in on neurotoxic aggregates

KANAZAWA, Japan, May 11, 2023 /PRNewswire/ — Researchers at Kanazawa University report in Nano Letters how high-speed atomic force microscopy leads to insights into processes relevant to Alzheimer’s disease. Moreover, the technique is shown to be an excellent tool for studying the effect of drugs against the disease. According to the amyloid hypothesis, Alzheimer’s disease … Read more

Navamedic ASA Q1 2023: Another strong quarter

OSLO, Norway, May 11, 2023 /PRNewswire/ — Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the first quarter of 2023. Navamedic experienced good momentum across the business and delivered another strong quarter, with record high revenues of NOK 121.7 million, … Read more